IL6 and Anxiety: Inflammatory signalling, such as increased brain-cortical TNF levels in conjunction with either increased IL-6 or IL-1β, and alterations in growth factor levels, e.g. brain derived neurotrophic factor and neuregulin, can contribute to the development of anxiety in eCM and behavioural sequelae [109–112].